ÕÅÐÞ‰b£¬ÄУ¬Ë¶Ê¿Ñо¿Éú£¬¼¹ÖùÍâ¿ÆÖ÷ÖÎҽʦ£¬2011Äê¾ÍÖ°ÓÚΫ·»ÊÐÒ涼ÖÐÐÄÒ½Ôº£¬2014Äê¾ÍÖ°ÓÚÇൺÊÐÖÐÐÄÒ½Ôº£¬É󤼹ÖùÍâ¿Æ¸÷ÖÖ³£¼û¼²²¡µÄÕï¶Ï¼°ÖÎÁÆ£¬ÌرðÊǶԸ÷ÖÖ¼¹Öù΢´´Î¢´´ÊÖÊõµÄÖÎÁÆ£¬ÔÚÄÜÐÖúÍê³É¸÷ÀྱÑü×µÍ˱äÐÔ¼²²¡µÄÊÖÊõ²Ù×÷¡£ ¿ÆÑÐÂÛÎÄ£º ÔÚÖлª¹ÇÓë¹Ø½ÚÍâ¿ÆÔÓÖ¾·¢±í¡¶Ë«²à¿×ÍÆ×¢Æ÷ÔھƤ´©´Ì×µÌå³ÉÐÎÊõÖеÄÁÙ´²Ó¦ÓüÛÖµ¡·£» ÔÚÖйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´ÔÓÖ¾·¢±í¡¶ÈýάCTAÑо¿×µ¶¯ÂöºáÍ»¶ÎµÄ×ßÐм°½âÆʱäÒì¡·¡¢¡¶MRIÓ°Ïñ²âÁ¿Ñü×µ»ÆÈÍ´øºñ¶ÈÓëÍ˱äÐÔ×µ¼äÅ̵ĹØϵ¡·, µÈ¹úÄÚºËÐÄÆÚ¿¯ÂÛÎÄ5ƪ£» ²ÎÓë׫дSCIÂÛÎÄ1ƪ£¬Oncology reports¡¶FOXN3 is downregulated in osteosarcoma and transcriptionally regulates SIRT6, and suppresses migration and invasion in osteosarcoma¡·£» ²ÎÓëÇൺÊпÎÌâ1Ï¸ÄÁ¼Ê½¾Æ¤´©´ÌÇòÄÒÀ©ÕÅ×µÌå³ÉÐÎÊõ£¨PKP£©ÖÎÁƹÇÖÊÊèËÉÐÔѹËõ¹ÇÕÛµÄÁÙ´²Ñо¿£¬µÚÎå룩£¬»ñµÃʵÓÃÐÔ·¢Ã÷רÀû1Ïî¡£ Éç»á¼æÖ°£º ÖлªÖÐҽҩѧ»á¼¹Öù΢´´×¨¼ÒίԱ»á ÇàÄêίԱ2018 SICOTÖйú²¿Î¢´´×¨Î¯»áµÚ¶þ½ìίԱ»á ίԱ 2019 |